Pediatrica Health Group, a rapidly expanding pediatric primary care organization, has successfully closed a $28 million Series B funding round. The investment was led by Boston-based growth equity firm Valspring Capital, with significant participation from existing investor M33 Growth. This new capital infusion is earmarked to accelerate the company's mission of delivering its innovative "Next Generation CareSM" model to more families across the United States.
Fueling Strategic Expansion
The proceeds from this funding round will provide the necessary capital to advance Pediatrica's strategic growth initiatives. The company plans to accelerate both organic expansion and pursue targeted acquisitions to broaden its geographic footprint. This investment will also support continued enhancements to its clinical infrastructure, operational capabilities, and proprietary technology platforms to better serve its patients.
According to CEO Roberto Palenzuela, the investment directly translates into expanded access, enabling more locations, providers, and resources for communities. He emphasized that the funding reflects the momentum Pediatrica has built and the confidence investors have in its family-first care model. The company's work aims to create a healthier next generation while easing long-term burdens on the broader healthcare system.
Investor Confidence in a New Care Model
Lead investor Valspring Capital brings deep sector expertise in healthcare innovation, making Pediatrica a compelling addition to its portfolio. Valspring focuses on growth-stage healthcare services companies that are transforming the industry. The firm was established by the former healthcare investment team of Bain Capital Ventures, underscoring its significant experience in scaling impactful health-focused enterprises.
Yumin Choi, Managing Partner of Valspring, stated that Pediatrica aligns with the firm's thesis that lasting change is driven by improving the patient and provider experience. He praised the company for building a unique model that nurtures communities and empowers providers. Choi also highlighted Pediatrica's commitment to expanding high-quality, coordinated care to all families, including those in underserved areas.
Continued Support from Founding Partner
The company's founding investment partner, M33 Growth, also participated in the round, reaffirming its commitment to Pediatrica's vision. The initial partnership with M33 was instrumental in propelling the organization's growth to its current 21 locations across Florida and Texas. M33 Growth will continue to play an active role in the company's ongoing strategic development and expansion efforts.
Gabe Ling, founder of M33, expressed his long-held belief in Roberto Palenzuela's vision for a superior pediatric care experience. He noted that the company's impressive growth is a testament to that vision and the team's relentless execution. Ling welcomed Valspring as a new partner, expressing excitement for the next chapter of growth that Pediatrica is now positioned to achieve.
A Vision for Pediatric Healthcare
Pediatrica Health Group is dedicated to creating better outcomes and brighter futures for both patient families and healthcare providers. Its unique model focuses on providing equitable access to innovative primary care for children from birth to 18 years of age. The organization empowers its clinical teams with modern technologies and resources to deliver exemplary, tailored patient care.
In conclusion, this $28 million Series B financing marks a significant milestone for Pediatrica Health Group, validating its innovative approach to pediatric primary care. With the backing of Valspring Capital and M33 Growth, the company is well-capitalized to scale its operations and bring its patient-centric model to more communities. This strategic investment will undoubtedly accelerate Pediatrica's journey toward reshaping the future of pediatric healthcare.